Gram J, Janetzko T, Jespersen J, Bruhn H D
Department of Internal Medicine, Klinikum der Christian-Albrechts-Universität, Kiel, Federal Republic of Germany.
Thromb Haemost. 1990 Apr 12;63(2):241-5.
The tissue-type plasminogen activator related fibrinolytic system was studied in 24 patients undergoing cardiopulmonary bypass surgery. The degradation of fibrinogen and fibrin was followed during and after surgery by means of new sensitive and specific assays and the changes were related to the blood loss measured in the chest tube drain during the first 24 postoperative hours. Although tissue-type plasminogen activator was significantly released into the circulation during the period of extracorporeal circulation (p less than 0.01), constantly low levels of fibrinogen degradation products indicated that a systemic generation of plasmin could be controlled by the naturally occurring inhibitors. Following extracorporeal circulation heparin was neutralized by protamine chloride, and in relation to the subsequent generation of fibrin, there was a short period with increased concentrations of fibrinogen degradation products (p less than 0.01) and a prolonged period of degradation of cross-linked fibrin, as detected by increased concentrations of D-Dimer until 24 h after surgery (p less than 0.01). Patients with a higher than the median blood loss (520 ml) in the chest tube drain had a significantly higher increase of D-Dimer than patients with a lower than the median blood loss (p less than 0.05). We conclude that the incorporation of tissue-type plasminogen activator into fibrin and the in situ activation of plasminogen enhance local fibrinolysis, thereby increasing the risk of bleeding in patients undergoing open heart surgery.
对24例接受体外循环手术的患者的组织型纤溶酶原激活物相关纤溶系统进行了研究。在手术期间及术后,通过新的敏感且特异的检测方法追踪纤维蛋白原和纤维蛋白的降解情况,并将这些变化与术后24小时内胸腔引流管中测得的失血量相关联。尽管在体外循环期间组织型纤溶酶原激活物显著释放到循环中(p<0.01),但纤维蛋白原降解产物水平持续较低表明纤溶酶的全身生成可被天然存在的抑制剂控制。体外循环后,用氯化鱼精蛋白中和肝素,与随后的纤维蛋白生成相关,有一段短时间纤维蛋白原降解产物浓度升高(p<0.01),且交联纤维蛋白降解期延长,这通过术后24小时内D - 二聚体浓度升高得以检测(p<0.01)。胸腔引流管中失血量高于中位数(520毫升)的患者,其D - 二聚体升高幅度显著高于失血量低于中位数的患者(p<0.05)。我们得出结论,组织型纤溶酶原激活物掺入纤维蛋白以及纤溶酶原的原位激活增强了局部纤溶作用,从而增加了心脏直视手术患者出血的风险。